PIK 3 CA mutation profiling in patients with breast cancer, using a highly sensitive detection system-Reference-Cited by-同舟云学术

PIK 3 CA mutation profiling in patients with breast cancer, using a highly sensitive detection system

Published:2018-07-28 Issue:8 Volume:109 Page:2558-2566
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Shimoi Tatsunori¹²^ORCID,Hamada Akinobu³,Yamagishi Marifu⁴,Hirai Mitsuharu⁴,Yoshida Masayuki⁵,Nishikawa Tadaaki¹^ORCID,Sudo Kazuki¹,Shimomura Akihiko¹,Noguchi Emi¹^ORCID,Yunokawa Mayu¹^ORCID,Yonemori Kan¹,Shimizu Chikako¹,Kinoshita Takayuki⁶,Fukuda Takahiro²⁷,Fujiwara Yasuhiro¹,Tamura Kenji¹^ORCID

Affiliation:

1. Department of Breast and Medical Oncology National Cancer Center Hospital Tokyo

2. Graduate School of Medicine Juntendo University Tokyo

3. Division of Molecular Pharmacology and Pharmacokinetics National Cancer Center Research Institute Tokyo

4. Research and Development Division ARKRAY, Inc. Kyoto

5. Department of Pathology and Clinical Laboratories National Cancer Center Hospital Tokyo

6. Department of Breast Surgery National Cancer Center Hospital Tokyo

7. Department of Hematopoietic Stem Cell Transplantation National Cancer Center Hospital Tokyo Japan

Funder

Health Labour Sciences Research Grant

Publisher

Wiley